|
|
|
|
|
|
|
|
|
|
open access
In conclusion, our study showed that high plasma Cbl (cobalamin) levels increased the risk of subsequently diagnosed cancer, mostly within the first year of follow-up. However, this association was not present for all cancer types. Although our results may have clinical implications for interpreting high Cbl levels, further studies are warranted to examine the possible diagnostic value of high plasma Cbl levels.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.